By Christian Moess Laursen GSK said it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an additional $400 million, the latest in.
By Christian Moess Laursen GSK said it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an.
By Christian Moess Laursen GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows a string of pharmaceutical.
GSK said it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an additional $400 million, the…
MARKET WRAPS Stocks: European stocks were back in the red on Tuesday despite a tech-led rally across other global markets. More weak German economic data added to the cautious mood. . -January 09, 2024 at 05:12 am EST
- MarketScreener